Universidade de São Paulo-ko ikertzaileekin lankidetzan egindako argitalpenak (11)

2024

  1. Characterizing the Atmospheric Mn Cycle and Its Impact on Terrestrial Biogeochemistry

    Global Biogeochemical Cycles, Vol. 38, Núm. 4

  2. Constraining Present-Day Anthropogenic Total Iron Emissions Using Model and Observations

    Journal of Geophysical Research: Atmospheres, Vol. 129, Núm. 17

2019

  1. Phosphorus pool responses under different P inorganic fertilizers for a eucalyptus plantation in a loamy Oxisol

    Forest Ecology and Management, Vol. 435, pp. 170-179

2010

  1. Thiram and Picloram as entrapping agents for lead depicted by electrochemical methods

    Journal of the Brazilian Chemical Society, Vol. 21, Núm. 6, pp. 1052-1059

2008

  1. New copper-based complexes with quinoxaline N1,N4-dioxide derivatives, potential antitumoral agents

    Journal of Inorganic Biochemistry, Vol. 102, Núm. 1, pp. 119-126

2007

  1. Synthetic chalcones, flavanones, and flavones as antitumoral agents: Biological evaluation and structure-activity relationships

    Bioorganic and Medicinal Chemistry, Vol. 15, Núm. 10, pp. 3356-3367

2006

  1. Selective hypoxia-cytotoxins based on vanadyl complexes with 3-aminoquinoxaline-2-carbonitrile-N1,N4-dioxide derivatives

    Journal of Inorganic Biochemistry, Vol. 100, Núm. 8, pp. 1358-1367

2005

  1. Novel Cu(II) quinoxaline N1,N4-dioxide complexes as selective hypoxic cytotoxins

    European Journal of Medicinal Chemistry, Vol. 40, Núm. 5, pp. 473-480

  2. Synthesis and biological properties of new 5-nitroindazole derivatives

    Bioorganic and Medicinal Chemistry, Vol. 13, Núm. 9, pp. 3197-3207

  3. Vanadium(V) complexes with salicylaldehyde semicarbazone derivatives bearing in vitro anti-tumor activity toward kidney tumor cells (TK-10): Crystal structure of [V VO 2(5-bromosalicylaldehyde semicarbazone)]

    Journal of Inorganic Biochemistry, Vol. 99, Núm. 2, pp. 443-451

2001

  1. 1,2,5-Oxadiazole N-oxide derivatives as potential anti-cancer agents: Synthesis and biological evaluation. Part IV

    European Journal of Medicinal Chemistry, Vol. 36, Núm. 10, pp. 771-782